SONM
DNA X·NASDAQ
--
--(--)
--
--(--)
SONM fundamentals
DNA X (SONM) released its earnings on Oct 31, 2025: revenue was 16.21M (YoY +7.94%), missed estimates; EPS was -4.83 (YoY +48.40%), missed estimates.
Revenue / YoY
16.21M
+7.94%
EPS / YoY
-4.83
+48.40%
Report date
Oct 31, 2025
EPS
Actual | -864 | -396 | -180 | -180 | -252 | -180 | -235.8 | -68.4 | -7.2 | 1.8 | -5.4 | -12.6 | -25.38 | -9.36 | -81 | 1.44 | -14.22 | -4.83 | |||||
Forecast | -552 | -420 | -324 | -234 | -180 | -180 | -108 | -90 | -36 | 1.8 | -5.4 | -9.72 | -11.88 | -7.2 | -2.34 | 0.72 | 5.4 | ||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | -56.52% | +5.71% | +44.44% | +23.08% | -40.00% | 0.00% | -118.33% | +24.00% | +80.00% | 0.00% | 0.00% | -400.00% | -133.33% | -161.11% | +21.21% | -1025.00% | +161.54% | -2075.00% | -189.44% |
Revenue
Actual | -- | -- | -- | -- | 12.71M | 21.06M | 14.39M | 15.80M | 12.24M | 11.95M | 14.45M | 13.26M | 20.50M | -- | 27.57M | 13.40M | 16.78M | 11.50M | 15.02M | 15.00M | 16.72M | 11.20M | 16.21M |
Forecast | -- | -- | -- | -- | 16.13M | 14.90M | 18.17M | 14.50M | 12.97M | 14.07M | 16.05M | 20.50M | 25.50M | -- | -- | 27.57M | 18.00M | 10.91M | 14.78M | 19.55M | 25.41M | 29.17M | 34.34M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | -21.24% | +41.33% | -20.77% | +8.97% | -5.60% | -15.02% | -10.00% | -35.33% | -19.62% | 0.00% | 0.00% | -51.39% | -6.80% | +5.39% | +1.63% | -23.29% | -34.20% | -61.60% | -52.79% |
Earnings Call
You can ask Aime
Did DNA X beat or miss consensus estimates last quarter?What guidance did DNA X's management provide for the next earnings period?What were the key takeaways from DNA X's earnings call?What does DNA X do and what are its main business segments?What is the market's earnings forecast for DNA X next quarter?What is DNA X's latest dividend and current dividend yield?What factors drove the changes in DNA X's revenue and profit?What is the revenue and EPS growth rate for DNA X year over year?
